TMHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Taylor Morrison Home Corp (TMHC) is not a strong buy for a beginner investor with a long-term focus at this moment. While the company has shown some positive catalysts such as exceeding Q1 earnings expectations and increasing its backlog, the significant YoY declines in revenue, net income, and EPS, coupled with mixed analyst sentiment and no strong trading signals, suggest that the stock may not be an optimal investment right now. Additionally, the technical indicators do not provide a compelling entry point, and the options data reflects a lack of significant bullish sentiment.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is in the neutral zone at 72.214, and moving averages are converging, showing no clear trend. Key resistance levels are at 65.264 and 67.494, while support levels are at 58.044 and 55.814. The stock is currently trading near resistance, suggesting limited immediate upside.
Q1 earnings exceeded Wall Street expectations, leading to a 5.5% stock increase.
Backlog increased by 23% to 3,465 homes, signaling strong demand.
Adjusted gross margin of 20.6% surpassed company guidance.
$1.6 billion in liquidity ensures financial stability.
Revenue dropped by 26.8% YoY, and net income fell by 53.8% YoY.
EPS decreased by 51.21% YoY, reflecting weaker profitability.
Analysts have mixed views, with some lowering price targets and expressing concerns about demand and gross margins.
Broader macroeconomic challenges, such as affordability headwinds and a volatile geopolitical backdrop, weigh on the housing market.
In Q1 2026, revenue declined by 26.84% YoY to $1.387 billion, net income dropped by 53.80% YoY to $98.62 million, and EPS fell by 51.21% YoY to $1.01. Gross margin also decreased to 21.54%, down 14.59% YoY. Despite these declines, the company reported strong liquidity of $1.6 billion and increased investment in land development.
Analyst sentiment is mixed. Wolfe Research, RBC Capital, and Barclays raised price targets and maintained Outperform/Overweight ratings, citing resilience in a challenging environment. However, Truist and Seaport Research lowered price targets, with Seaport issuing a Sell rating due to concerns about slowing housing activity and weak demand. The average price target ranges from $68 to $80, with some analysts expressing caution about macroeconomic and affordability challenges.
